Mallinckrodt Announces 2019 Investigator Award for Pioneering Efforts in ECP Immunomodulation
Staines-Upon-Thames, England (ots/PRNewswire) - EUR50,000 award goes to Newcastle University, in collaboration with Medical University, Graz and Newcastle Hospitals NHS Foundation Trust Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced the recipient of 2019's Advancing Extracorporeal Photopheresis (ECP) Immunomodulation ...